Xiangyuan Liu

ORCID: 0009-0005-8513-0879
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Autoimmune and Inflammatory Disorders Research
  • Monoclonal and Polyclonal Antibodies Research
  • Quantum Information and Cryptography
  • Quantum Mechanics and Applications
  • Chronic Lymphocytic Leukemia Research
  • Interconnection Networks and Systems
  • Low-power high-performance VLSI design
  • Quantum Computing Algorithms and Architecture
  • Bone Metabolism and Diseases
  • Cytokine Signaling Pathways and Interactions
  • Adaptive optics and wavefront sensing
  • Parallel Computing and Optimization Techniques
  • Embedded Systems Design Techniques
  • Bone health and treatments
  • DNA and Nucleic Acid Chemistry
  • Atmospheric and Environmental Gas Dynamics
  • Image Retrieval and Classification Techniques
  • Optical Systems and Laser Technology
  • Recommender Systems and Techniques
  • Immunodeficiency and Autoimmune Disorders
  • Educational Technology and Pedagogy
  • Diabetes and associated disorders
  • Atmospheric chemistry and aerosols

West Anhui University
2011-2024

China University of Petroleum, Beijing
2021-2024

National University of Malaysia
2024

Shenyang Jianzhu University
2024

Dalian Maritime University
2024

Beijing Normal University
2018-2023

Shandong University
2021-2023

National University of Defense Technology
2006-2023

Hunan University of Arts and Science
2023

Shandong University of Science and Technology
2021-2022

Environmental factors play an important role in the development of rheumatoid arthritis (RA). Among these factors, smoking is generally considered to be established risk factor for RA. Data regarding impact diet on RA limited. This study assessed dietary patterns susceptibility Chinese populations. was a large scale, case-control composed 968 patients with and 1037 matched healthy controls. Subjects were recruited from 18 teaching hospitals. Socio-demographic characteristics intakes 5 years...

10.1007/s10067-016-3383-x article EN cc-by Clinical Rheumatology 2016-08-23

Recommender systems that learn from implicit feedback often use large volumes of a single type user feedback, such as clicks, to enhance the prediction sparse target behavior purchases. Using multiple types for purposes is still an open question. Existing studies attempted fail to: (i) universal and accurate preferences different behavioral data distributions, (ii) overcome noise bias in observed feedback.

10.1145/3539618.3591697 article EN Proceedings of the 45th International ACM SIGIR Conference on Research and Development in Information Retrieval 2023-07-18

The aims of this study are to characterize the biological disease-modifying antirheumatic drug (bDMARD) usage patterns in real-life and examine remission rate rheumatoid arthritis (RA) patients receiving bDMARDs routine clinical practice China. Consenting RA (≥18 years) from 15 teaching hospitals marketed were included. In total, 802 (81.3 % women, 49.0 ± 13.9 included; 89.5 a combination conventional synthetic DMARDs (csDMARDS), whereas 10.5 bDMARD monotherapy. Etanercept (including Enbrel®...

10.1007/s10067-016-3424-5 article EN cc-by Clinical Rheumatology 2016-10-05

Vector-SIMD architectures have gained increasing attention because of their high performance in signal-processing applications. However, the existing vector-SIMD remains limited inefficiency coordinated exploitation different hardware units. To solve this problem, article proposes FT-Matrix architecture, which improves coordination traditional from three aspects: cooperation between scalar and SIMD unit is refined with dynamic coupling execution scheme, communication among lanes enhanced...

10.1109/mm.2013.129 article EN IEEE Micro 2014-01-31

Objectives: To determine whether prolonged intensive disease-modifying antirheumatic drug (DMARD) treatment (PRINT) leads to high remission and low relapse rates in patients with severe rheumatoid arthritis (RA). Methods: In this multicenter, randomized parallel trial, 346 active RA (disease activity score (28 joints) [DAS28] (erythrocyte sedimentation rate [ESR]) > 5.1) were enrolled from 9 centers. phase 1, received methotrexate, leflunomide, hydroxychloroquine, up 36 weeks, until (DAS28 ≤...

10.1097/md.0000000000003968 article EN cc-by-nc Medicine 2016-07-01

DR and next query prediction (NQP) are two core tasks in session search. They often driven by the same search intent and, hence, it is natural to jointly optimize both tasks. So far, most models proposed for optimizing document reranking (DR) NQP have focused on users' short-term an ongoing session. Because of this limitation, these fail account long-term as captured their historical sessions. In contrast, we consider a personalized mechanism learning user's profile from behavior...

10.1145/3442381.3449941 article EN 2021-04-19

BackgroundThere is heterogeneity in the clinical manifestations and responses to drugs RA patients due variety of factors such as genes environment. Despite advances treatment rheumatoid arthritis (RA), approximately 40% still do not achieve primary outcomes randomized trials, its low remission rate high economic consumption remain unresolved, especially developing countries. Iguratimod (IGU) a new disease-modifying anti-rheumatic drug (DMARD) with price that has demonstrated good efficacy...

10.1016/j.lanwpc.2021.100128 article EN cc-by-nc-nd The Lancet Regional Health - Western Pacific 2021-03-23

Objective Several studies have reported STAT4 polymorphism is strongly associated with increased susceptibility to rheumatoid arthritis (RA). However, a study from China showed no association between and RA in Chinese Han subpopulation. Since the northern Hans are known be genetically different southern Hans, aim of this was investigate large cohort Methods 640 patients 662 healthy controls were enrolled. DNA samples genotyped for rs7574865 by direct sequencing. The single nucleotide (SNP)...

10.1111/1756-185x.12093 article EN International Journal of Rheumatic Diseases 2013-04-01
Coming Soon ...